HC Wainwright Analysts Cut Earnings Estimates for Transcat

Transcat, Inc. (NASDAQ:TRNS) – HC Wainwright cut their Q3 2025 earnings per share estimates for Transcat in a report issued on Wednesday, October 30th. HC Wainwright analyst S. Buck now forecasts that the scientific and technical instruments company will post earnings of $0.29 per share for the quarter, down from their prior forecast of $0.43. HC Wainwright currently has a “Buy” rating and a $156.00 price target on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.06 per share. HC Wainwright also issued estimates for Transcat’s FY2025 earnings at $1.60 EPS and FY2026 earnings at $1.83 EPS.

Other equities research analysts also recently issued reports about the stock. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday. Craig Hallum reduced their price objective on Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a report on Wednesday. Oppenheimer reiterated an “outperform” rating and set a $130.00 target price (down from $155.00) on shares of Transcat in a research report on Wednesday. Finally, Northland Securities dropped their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research report on Wednesday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Transcat currently has an average rating of “Hold” and an average target price of $127.25.

Transcat Trading Down 3.5 %

TRNS stock opened at $95.57 on Friday. The company’s 50-day moving average price is $122.34 and its 200 day moving average price is $121.99. Transcat has a 52 week low of $84.45 and a 52 week high of $147.12. The company has a market cap of $874.47 million, a P/E ratio of 48.27 and a beta of 0.67.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). The company had revenue of $67.83 million for the quarter, compared to analysts’ expectations of $70.30 million. Transcat had a return on equity of 7.62% and a net margin of 6.63%. Transcat’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.41 earnings per share.

Institutional Investors Weigh In On Transcat

A number of institutional investors and hedge funds have recently bought and sold shares of TRNS. Conestoga Capital Advisors LLC raised its stake in Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after purchasing an additional 137,830 shares during the last quarter. Hood River Capital Management LLC grew its holdings in shares of Transcat by 21.6% during the second quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock worth $23,558,000 after buying an additional 34,947 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Transcat by 28.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock valued at $9,577,000 after buying an additional 17,743 shares during the last quarter. Raymond James & Associates lifted its stake in shares of Transcat by 157.2% during the third quarter. Raymond James & Associates now owns 20,651 shares of the scientific and technical instruments company’s stock valued at $2,494,000 after buying an additional 12,622 shares during the period. Finally, Janus Henderson Group PLC boosted its position in Transcat by 208.3% during the first quarter. Janus Henderson Group PLC now owns 10,297 shares of the scientific and technical instruments company’s stock worth $1,147,000 after acquiring an additional 6,957 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.